UiPath (PATH) CFO exercises 148,009 options; sales around $17.0122
UiPath (PATH) COO & CFO Ashim Gupta reported insider transactions on 10/09/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UiPath (PATH) COO & CFO Ashim Gupta reported insider transactions on 10/09/2025. He exercised 148,009 stock options at $0.7533 per share and executed open‑market sales under a Rule 10b5‑1 trading plan.
Sales were reported in three blocks: 181,745 shares at an average price of $17.0122 (range $16.2800–$17.2700), 32,144 shares at $17.7403 (range $17.2800–$18.2700), and 26,985 shares at $18.5263 (range $18.2800–$18.7300). Following these transactions, he directly owned 696,117 Class A shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 148,009 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 148,009 | $0.7533 | $111K |
| Sale | Class A Common Stock | 181,745 | $17.0122 | $3.09M |
| Sale | Class A Common Stock | 32,144 | $17.7403 | $570K |
| Sale | Class A Common Stock | 26,985 | $18.5263 | $500K |
Footnotes (5)
- F1. The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- F2. The range of prices for the transactions reported was from $16.2800 to $17.2700. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3. The range of prices for the transactions reported was from $17.2800 to $18.2700. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F4. The range of prices for the transactions reported was from $18.2800 to $18.7300. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5. The shares underlying this stock option vest over 4 years, with 25% vesting after the first year, and the remaining shares vesting in equal monthly installments beginning on February 6, 2019, subject to continuous service through each such vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PATH's COO & CFO report on the Form 4?
Was the trading pre‑arranged under a 10b5‑1 plan?
What role does the reporting person hold at UiPath (PATH)?
What is the option exercise price and instrument type?
AI-generated analysis. How Rhea-AI works. Not financial advice.